Plasma renin activity during levodopa therapy. Significance of long- and short-term treatment.
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004032:Diet; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D011187:Posture; D011188:Potassium / Q000097:blood / Q000652:urine; D051381:Rats; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood / Q000652:urine; D013997:Time Factors
D000804:Angiotensin II; D000450:Aldosterone; D004295:Dihydroxyphenylalanine; D012964:Sodium; D012083:Renin; D011188:Potassium